Sanofi (SNY) Event May 16, 2022, 17:45 UTC (90% Positive) Sanofi (SNY) Reports Q2 2022 Financial Results (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 4:56 p.m. 🌍 Sanofi (SNY) - Form 6-K Filing Filing Date: 2022-05-16 Accepted: 2022-05-16 13:45:00 Event Type: Financial Results Event Details: Q1 2022 sales growth driven by Dupixent and CHC. Business operating income (BOI) margin up reflecting improvement in gross margin while investing in RD. Business EPS(1) up 16.1% at CER driven by higher sales and improving margins. 💼 Business Developments: ✅ Partnership/Collaboration✅ Acquisition Activity✅ Licensing Agreement✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: sandrine.guendoul@sanofi.com
🌍 Sanofi (SNY) - Form 6-K Filing
Filing Date: 2022-05-16
Accepted: 2022-05-16 13:45:00
Event Type: Financial Results
Event Details:
💼 Business Developments:
📞 Contact Information: